ESMO Asia Virtual Oncology Week 2021

Search results (11)

14 Oct 2021

ESMO Asia Virtual Oncology Week 2021

Watch video

Breast Cancer

20 Nov 2021

Some practice-changing results in breast cancer are perceived differently in low-resourced countries

Read more

Gastrointestinal cancers

20 Nov 2021

What is the impact of first-line nivolumab on subsequent therapy choices for metastatic gastric cancer?

Read more

Bioethics, legal and economic issues

20 Nov 2021

Do biosimilars improve access to oncology medicines in Asia?

Biosimilars make certain medicines more affordable, but cost and availability drive the need to find ways to improve access

By Elisabeth de Vries

Read more

Gastrointestinal cancers

20 Nov 2021

New data for management of hepatocellular carcinoma

Read more

Lung and other thoracic tumours

20 Nov 2021

Encouraging results with sintilimab combination therapy in EGFR-mutated non-squamous NSCLC

Read more

Genitourinary cancers

20 Nov 2021

Should renal cell carcinomas be managed differently in Asia?

Read more

Head and neck cancers

20 Nov 2021

Genetics and availability of treatments influence the management of head and neck cancer in Asia

Read more

Cancer in Special Situations / Population

20 Nov 2021

How can quantifying the burden of rare cancers in Asia improve patient outcomes?

National cancer control programmes, pharmaceutical company interest and facilitation of clinical trial participation may be stimulated by epidemiological data

By Tomohiro Matsuda

Read more

Gastrointestinal cancers

20 Nov 2021

Tailoring the management of localised colon cancer to the Asian population

Read more